找化学品上960化工网!
960化工网

新生霉素 | 303-81-1

新生霉素结构式图片|303-81-1结构式图片
新生霉素
Novobiocin
303-81-1
C31H36N2O11
612.62434
如需查看该化合物的详细结构式,mol文件,smile,InChi 请点击:新生霉素结构式
54675769
新生霉素价格
简介
新生霉素(novobiocin)是一种抗生素,为香豆素类抗生素的代表药物,对DNA回旋酶有很好的抑制作用,对多种癌细胞有抑制作用,并能与抗癌药联合应用,逆转抗癌药的耐药性。
名称和标识符
MDL MFCD00072100
InChIKey YJQPYGGHQPGBLI-KGSXXDOSSA-N
Inchi InChI=1S/C31H36N2O11/c1-14(2)7-8-16-13-17(9-11-19(16)34)27(37)33-21-22(35)18-10-12-20(15(3)24(18)42-28(21)38)41-29-23(36)25(43-30(32)39)26(40-6)31(4,5)44-29/h7,9-13,23,25-26,29,34-36H,8H2,1-6H3,(H2,32,39)(H,33,37)/t23-,25+,26-,29-/m1/s1
SMILES C/C(=C/CC1C(O)=CC=C(C(NC2C(=O)OC3C(=C(O[C@@H]4OC(C)(C)[C@H](OC)[C@@H](OC(=O)N)[C@H]4O)C=CC=3C=2O)C)=O)C=1)/C
别名信息
- 中文别名 -
  • 新生霉素
  • 新生霉素 USP标准品
  • 新生霉素A
- 英文别名 -
  • Novobiocin
  • Streptonivicin
  • Notonesomycin
  • Albamix
  • Albamycin
  • Antibiotic PA-93
  • Cardelmycin
  • Cathocin
  • Cathomycin
  • Crystallinic acid
  • Inamycin
  • Novo-R
  • PA 93
  • Robiocina
  • Sirbiocina
  • Spheromycin
  • Stilbiocina
  • U 6391
  • Novobiocinum (INN-Latin)
  • EINECS 206-146-3
  • Biotexin
  • GTPL12021
  • 17EC19951N
  • EN300-19736048
  • (3R,4S,5R,6R)-5-hydroxy-6-[(2-hydroxy-3-{[4-hydroxy-3-(3-methylbut-2-en-1-yl)benzene]amido}-8-methyl-4-oxo-4H-chromen-7-yl)oxy]-3-methoxy-2,2-dimethyloxan-4-yl carbamate
  • Novobiocine (INN-French)
  • A-256
  • Carbamic acid (3R,4S,5R,6R)-5-hydroxy-6-{4-hydroxy-3-[4-hydroxy-3-(3-methyl-but-2-enyl)-benzoylamino]-8-methyl-2-oxo-2H-chromen-7-yloxy}-3-methoxy-2,2-dimethyl-tetrahydro-pyran-4-yl ester
  • MEGxm0_000273
  • KBio2_006617
  • KBioGR_002402
  • Novobiocina
  • BENZAMIDE, N-(7-((3-O-(AMINOCARBONYL)-6-DEOXY-5-C-METHYL-4-O-METHYL-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-4-HYDROXY-8-METHYL-2-OXO-2H-1-BENZOPYRAN-3-YL)-4-HYDROXY-3-(3-METHYL-2-BUTEN-1-YL)-
  • MLS001032086
  • DivK1c_000260
  • HY-B0425
  • AI3-50148
  • Spectrum2_000977
  • Carbamic acid (3R,4S,5R,6R)-5-hydroxy-6-{4-hydroxy-3-[4-hydroxy-3-(4-methyl-pent-3-enyl)-benzoylamino]-8-methyl-2-oxo-2H-chromen-7-yloxy}-3-methoxy-2,2-dimethyl-tetrahydro-pyran-4-yl ester
  • Spectrum_001001
  • NOVOBIOCIN [USP-RS]
  • BENZAMIDE, N-(7-((3-O-(AMINOCARBONYL)-6-DEOXY-5-C-METHYL-4-O-METHYL-.BETA.-L-LYXO-HEXOPYRANOSYL)OXY)-4-HYDROXY-8-METHYL-2-OXO-2H-1-BENZOPYRAN-3-YL)-4-HYDROXY-3-(3-METHYL-2-BUTENYL)-
  • 7-(3-(O-Carbamoyl)-4-(O-methyl)-5,5-dimethyl-alpha-L-lyxopyranosyloxy)-4-hydroxy-3-(4-hydroxy-3-(3-methyl-2-butenyl)benzamidol)-8-methylcumarin
  • NS00010563
  • Novobiocine [INN-French]
  • ACon0_000808
  • C05080
  • KBio2_007538
  • N-{7-[(3-O-carbamoyl-6-deoxy-5-methyl-4-O-methyl-beta-D-gulopyranosyl)oxy]-4-hydroxy-8-methyl-2-oxo-2H-chromen-3-yl}-4-hydroxy-3-(3-methylbut-2-en-1-yl)benzamide
  • NOVOBIOCIN [VANDF]
  • Benzamide, N-(7-((3-O-(aminocarbonyl)-6-deoxy-5-C-methyl-4-O-methyl-beta-L-lyxo-hexopyranosyl)oxy)-4-hydroxy-8-methyl-2-oxo-2H-1-benzopyran-3-yl)-4-hydroxy-3-(3-methyl-2-butenyl)-
  • KBio3_001615
  • (3R,4S,5R,6R)-5-hydroxy-6-{[4-hydroxy-3-({[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]carbonyl}amino)-8-methyl-2-oxo-2H-chromen-7-yl]oxy}-3-methoxy-2,2-dimethyltetrahydro-2H-pyran-4-yl carbamate
  • (3R,4S,5R,6R)-5-Hydroxy-6-((4-hydroxy-3-(4-hydroxy-3-(3-methylbut-2-en-1-yl)benzamido)-8-methyl-2-oxo-2H-chromen-7-yl)oxy)-3-methoxy-2,2-dimethyltetrahydro-2H-pyran-4-yl carbamate
  • KBio2_004049
  • HSDB 7443
  • SPBio_001013
  • NOVOBIOCIN [MI]
  • Coumarin, 7-(4-(carbamoyloxy)tetrahydro-3-hydroxy-5-methoxy-6,6-dimethylpyran-2-yloxy)-4-hydroxy-3-(4-hydroxy-3-(4-hydroxy-3-(3-methyl-2-butenyl)benzamido)-8-methyl-
  • 1aj6
  • BENZAMIDE, N-(7-((3-O-(AMINOCARBONYL)-6-DEOXY-5-C-METHYL-4-O-METHYL-alpha-L-LYXO-HEXOPYRANOSYL)OXY)-4-HYDROXY-8-METHYL-2-OXO-2H-1-BENZOPYRAN-3-YL)-4-HYDROXY-3-(3-METHYL-2-BUTEN-1-YL)-
  • Novobiocin [INN:BAN]
  • ACon1_001693
  • NINDS_000260
  • Vulcamicina
  • Carbamic acid 5-hydroxy-6-{4-hydroxy-3-[4-hydroxy-3-(3-methyl-but-2-enyl)-benzoylamino]-8-methyl-2-oxo-2H-chromen-7-yloxy}-3-methoxy-2,2-dimethyl-tetrahydro-pyran-4-yl ester(Novobiocin)
  • [(3R,4S,5R,6R)-5-hydroxy-6-[4-hydroxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-8-methyl-2-oxo-chromen-7-yl]oxy-3-methoxy-2,2-dimethyl-tetrahydropyran-4-yl] carbamate
  • IDI1_000260
  • NCGC00188981-01
  • (3R,4S,5R,6R)-5-hydroxy-6-(4-hydroxy-3-(4-hydroxy-3-(3-methylbut-2-enyl)benzamido)-2-oxo-2H-chromen-7-yloxy)-3-methoxy-2,2-dimethyl-tetrahydro-2H-pyran-4-yl carbamate
  • KBio2_001481
  • W-204218
  • KBio2_002402
  • Novobiocine
  • NOVOBIOCIN [GREEN BOOK]
  • BSPBio_002115
  • KBioSS_001481
  • (3R,4S,5R,6R)-5-hydroxy-6-(4-hydroxy-3-(4-hydroxy-3-(3-methylbut-2-enyl)benzamido)-8-methyl-2-oxo-2H-chromen-7-yloxy)-3-methoxy-2,2-dimethyltetrahydro-2H-pyran-4-yl carbamate
  • BDBM282
  • SCHEMBL238345
  • 4uro
  • Novobiocinum [INN-Latin]
  • DTXCID1021083
  • NOVOBIOCIN [WHO-DD]
  • SMR000718617
  • KBio2_004970
  • (3R,4S,5R,6R)-5-hydroxy-6-[(4-hydroxy-3-{[4-hydroxy-3-(3-methylbut-2-en-1-yl)benzene]amido}-8-methyl-2-oxo-2H-chromen-7-yl)oxy]-3-methoxy-2,2-dimethyloxan-4-yl carbamate
  • KBioSS_002407
  • NOVOBIOCIN (MART.)
  • AKOS027295139
  • Novobiocinum
  • Albamix Feed Medication
  • NOVOBIOCIN [INN]
  • Vulkamycin
  • 4urn
  • KBio1_000260
  • BRD-K85307935-236-02-0
  • [(3R,4S,5R,6R)-5-hydroxy-6-[4-hydroxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-8-methyl-2-oxochromen-7-yl]oxy-3-methoxy-2,2-dimethyloxan-4-yl] carbamate
  • CHEMBL36506
  • 7-(Carbamoyltetrahydro-3-hydroxy-5-methoxy-6,6-dimethylpyran-2-yloxy)-4-hydroxy-3-(4-hydroxy-3-(3-methylbut-2-enyl)benzamide)-8-methyl-2H-chromen-2-one
  • Spectrum4_000457
  • UNII-17EC19951N
  • cMAP_000043
  • AT38053
  • CHEBI:28368
  • Spectrum3_000528
  • (3R,4S,5R,6R)-5-hydroxy-6-({4-hydroxy-3-[4-hydroxy-3-(3-methylbut-2-en-1-yl)benzamido]-8-methyl-2-oxo-2H-chromen-7-yl}oxy)-3-methoxy-2,2-dimethyloxan-4-yl carbamate
  • 1476-53-5
  • Novobiocina [INN-Spanish]
  • NSC2382
  • DB01051
  • (3R,4S,5R,6R)-5-hydroxy-6-(4-hydroxy-3-(4-hydroxy-3-(3-methylbut-2-enyl)benzamido)-8-methyl-2-oxo-2H-chromen-7-yloxy)-3-methoxy-2,2-dimethyl-tetrahydro-2H-pyran-4-yl carbamate
  • NOV
  • Q1639291
  • N-[7-[[3-O-(Aminocarbonyl)-6-deoxy-5-C-methyl-4-O-methyl-.beta.-L-lyxo-hexopyranosyl]oxy]-4-hydroxy-8-methyl-2-oxo-2H-1-benzopyran-3-yl]-4-hydroxy-3-(3-methyl-2-butenyl)
  • NOVOBIOCIN (USP-RS)
  • 303-81-1
  • SCHEMBL24805
  • Streptonivicin (*Sodium salt*)
  • NOVOBIOCIN [MART.]
  • KBio3_002881
  • CS-0082991
  • NOVOBIOCIN [HSDB]
  • novobiocin
  • Spectrum5_001274
  • Novobiocina (INN-Spanish)
  • BDBM50226181
  • DTXSID3041083
  • Novobiocin, Antibiotic for Culture Media Use Only
  • Carbamic acid 5-hydroxy-6-{4-hydroxy-3-[4-hydroxy-3-(3-methyl-but-2-enyl)-benzoylamino]-8-methyl-2-oxo-2H-chromen-7-yloxy}-3-methoxy-2,2-dimethyl-tetrahydro-pyran-4-yl ester
  • Novobiocin 1000 microg/mL in Acetonitrile
  • KBioGR_000874
物化性质
实验特性
LogP 4.40040
PSA 200.01000
折射率 1.5800 (estimate)
沸点 657.29°C (rough estimate)
熔点 174-178 ºC (分解)
蒸气压 No date available
闪点 466.8°C
溶解度 Insuluble (6.1E-3 g/L) (25 ºC),
颜色与性状 Solid
酸度系数(pKa) pKa1 4.3; pKa2 9.1(at 25℃)
比旋光度 D24 -63.0° (c = 1 in ethanol)
密度 1.42±0.1 g/cm3 (20 ºC 760 Torr),
计算特性
精确分子量 612.23200
氢键供体数量 5
氢键受体数量 11
可旋转化学键数量 9
同位素质量 612.232
重原子数量 44
复杂度 1150
同位素原子数量 0
确定原子立构中心数量 4
不确定原子立构中心数量 0
确定化学键立构中心数量 0
不确定化学键立构中心数量 0
共价键单元数量 1
疏水参数计算参考值(XlogP) 3.3
拓扑分子极性表面积 196A^2
国际标准相关数据
EINECS 206-146-3
专业数据库参考
PubChemId 54675769
化合物详情(旧版)

物理化学性质

产品用途

应用领域







上下游产品信息




化学品安全说明书(MSDS)



储运特性





960化工网为您提供新生霉素专业化合物百科信息,包括中文名,英文名,分子式,分子量,以及该化合物的CasNo.:303-81-1,和相关理化性质;并提供了优质生产厂家信息包括厂家名称和联系方式等;| WAP 版:303-81-1
平台客服 平台客服

平台在线客服